Reprint

Antimicrobial Resistance and Anti-Biofilms

Edited by
March 2023
164 pages
  • ISBN978-3-0365-6951-2 (Hardback)
  • ISBN978-3-0365-6950-5 (PDF)

This book is a reprint of the Special Issue Antimicrobial Resistance and Anti-Biofilms that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

This reprint is based on “Antimicrobial resistance and anti-biofilms” in the journal Antibiotics since November of 2020. This reprint has one editorial article, eight research articles, one review article, and one case report article, covering a time period of 15 months from December of 2021 to February of 2023. Containing three major sub-topics in this reprint, four manuscripts regarding the prevalence of resistant microbes, the emergence and evolution of resistance, and the molecular investigation of resistance mechanisms fall into the first sub-topic as “Antimicrobial resistance in microorganisms: epidemiology and molecular mechanism”; three manuscripts fall into the second sub-topic as “New antibiofilm strategy against fungal and/or bacterial biofilms”; and three manuscripts regarding the production and characteristics of these functional material encapsulated/ delivered natural compounds, in vitro and in vivo antimicrobial and antivirulent effects, and their potential applications, such as in food and medicine, fall into the third sub-topic as “Influence of Functional Material-Based Encapsulation/Delivery on the Antimicrobial and Antivirulent Effects of Natural Compounds”. Articles contained in this reprint have provided comprehensive knowledge and insight in understanding of antimicrobial resistance epidemiology and molecular mechanism and new antibiofilm strategies.

Format
  • Hardback
License
© by the authors
Keywords
carbapenem-resistant Enterobacteriaceae; metallo-β-lactamases; NDM producers; complicated urinary tract infections; outcomes; costs; burden of illness; Medicare; Serratia marcescens; multidrug resistance; mcr-9; blaIMP-26; megaplasmids IMP-26; evolutionary pathway; Canarium patentinervium Miq.; multidrug resistance; antibiofilm activity; AcrAB-TolC efflux pump; molecular docking; Autodock Vina; Staphylococcus aureus; persisters; biofilm; antimicrobial activity; drug combination; Ralstonia mannitolilytica; chronic obstructive pulmonary disease (COPD); catheter-related bloodstream infection (CRBSI); commensal; pathogen; chitosan; nanoparticle; antibiofilm; cinnamaldehyde; Staphylococcus aureus; antibiofilm; invasive plants; natural products; molecular networking; Staphylococcus aureus; Candida albicans; betulinic acid; Staphylococcus aureus; biofilms; extracellular matrix; quorum sensing; antibiofilm; antibiotic resistance; Streptococcus mutans; biofilm; extracellular matrix; dental caries; Casearia sylvestris